ridm@nrct.go.th   ระบบคลังข้อมูลงานวิจัยไทย   รายการโปรดที่คุณเลือกไว้

COST-BENEFIT ANALYSIS OF CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING: A CASE OFCHULALONGKORN MEMORIAL HOSPITAL, THAILAND

หน่วยงาน ฐานข้อมูลวิทยานิพนธ์ไทย

รายละเอียด

ชื่อเรื่อง : COST-BENEFIT ANALYSIS OF CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING: A CASE OFCHULALONGKORN MEMORIAL HOSPITAL, THAILAND
นักวิจัย : Nutta Sreshthaputra
คำค้น : COST-BENEFIT ANALYSIS , CONGENITAL HYPOTHYROIDISM , NEONATAL SCREENING , EARLYDETECTION AND TREATMENT , CHULALONGKORN MEMMORIAL HOSPITAL
หน่วยงาน : ฐานข้อมูลวิทยานิพนธ์ไทย
ผู้ร่วมงาน : -
ปีพิมพ์ : 2542
อ้างอิง : http://www.thaithesis.org/detail.php?id=1082542000560
ที่มา : -
ความเชี่ยวชาญ : -
ความสัมพันธ์ : -
ขอบเขตของเนื้อหา : -
บทคัดย่อ/คำอธิบาย :

In many industrialized countries, neonatal screening program for congenitalhypothyroidism was introduced since 1970s and now becomes a routine. Generally,neonatal screening programs for Congenital Hypothyroidism are established on a purelymedical basis for disability prevention with some notions of cost-benefit advantages. This empirical study is based on the screening program at ChulalongkornHospital. Its objective is to provide an evidence of cost-benefit analysis of the TSHscreening program for congenital hypothyroidism in newborn. Both costs and benefitsare considered from three perspectives: provider, patient and society. Thebenefit-cost ratio is assessed at two levels: hospital-based and national policy. Thescreening program at Chulalongkorn Hospital shows that the incidence rate ofCongenital Hypothyroidism is 1 per 2,907 live births, the recall rate is 0.24%according to acceptable criteria for TSH cut off level while the responsive-recallrate and the compliance rate are 71.77% and 100%, respectively. The average costs percase prevented for provider and for patient are 51,169 and 91,833 Baht. The estimatedtotal present value of benefits from the screening program are 993,941.01 Baht percase prevented. The benefit-cost ratio of the base case (at Chulalongkorn Hospital)is 2.19. The analysis at national policy level has the benefit-cost ratio of 2.70.The benefit-cost ratio is sensitive to three major factors: incidence rate,responsive recall rate and patient compliance rate. When the incidence rate, theresponsive-recall rate and the compliance rate are adjusted, the benefit-cost ratioremains greater than one.

บรรณานุกรม :
Nutta Sreshthaputra . (2542). COST-BENEFIT ANALYSIS OF CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING: A CASE OFCHULALONGKORN MEMORIAL HOSPITAL, THAILAND.
    กรุงเทพมหานคร : ฐานข้อมูลวิทยานิพนธ์ไทย.
Nutta Sreshthaputra . 2542. "COST-BENEFIT ANALYSIS OF CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING: A CASE OFCHULALONGKORN MEMORIAL HOSPITAL, THAILAND".
    กรุงเทพมหานคร : ฐานข้อมูลวิทยานิพนธ์ไทย.
Nutta Sreshthaputra . "COST-BENEFIT ANALYSIS OF CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING: A CASE OFCHULALONGKORN MEMORIAL HOSPITAL, THAILAND."
    กรุงเทพมหานคร : ฐานข้อมูลวิทยานิพนธ์ไทย, 2542. Print.
Nutta Sreshthaputra . COST-BENEFIT ANALYSIS OF CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING: A CASE OFCHULALONGKORN MEMORIAL HOSPITAL, THAILAND. กรุงเทพมหานคร : ฐานข้อมูลวิทยานิพนธ์ไทย; 2542.